- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,445GBP
- Report
- September 2026
- 196 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 181 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- November 2025
- 130 Pages
Middle East
From €5468EUR$5,950USD£4,565GBP
- Report
- June 2026
- 403 Pages
Global
From €4411EUR$4,799USD£3,682GBP
- Report
- March 2026
- 383 Pages
Global
From €4549EUR$4,950USD£3,798GBP
- Report
- September 2026
- 200 Pages
Global
From €2288EUR$2,490USD£1,910GBP
- Report
- April 2026
- 120 Pages
Global
From €5468EUR$5,950USD£4,565GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4127EUR$4,490USD£3,445GBP
- Report
- September 2026
- 187 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 186 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 185 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 180 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 186 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- September 2026
- 190 Pages
Global
From €3258EUR$3,545USD£2,720GBP
€3620EUR$3,939USD£3,022GBP
- Report
- November 2026
- 180 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 257 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- November 2026
- 179 Pages
Global
From €5377EUR$5,850USD£4,488GBP
- Report
- September 2026
- 180 Pages
Global
From €4366EUR$4,750USD£3,644GBP

The Tumor Marker market is a segment of the In Vitro Diagnostics (IVD) industry. It is composed of products used to detect the presence of cancer in a patient. These products are typically used to diagnose, monitor, and assess the effectiveness of cancer treatments. Tumor markers are typically proteins, hormones, or other substances that are produced by cancer cells or by the body in response to cancer. They can be detected in the blood, urine, or other body fluids.
The Tumor Marker market is a rapidly growing segment of the IVD industry, driven by the increasing prevalence of cancer and the need for early diagnosis and effective treatment. The market is expected to continue to grow in the coming years, driven by technological advancements and the development of new products.
Some of the major companies in the Tumor Marker market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more